HUTCHMED (China) Ltd (HCM) EBITDA Margin (2015 - 2021)

HUTCHMED (China) (HCM) has reported EBITDA Margin for 6 consecutive years, with 172.21% the latest figure, recorded in Q4 2021.

• On a quarterly basis, EBITDA Margin changed N/A year-over-year to 172.21% in Q4 2021; TTM through Dec 2021 was 20.62%, a N/A change from a year earlier, with the FY2025 full-year figure at 7.14%, down 20.0% from the prior year.
• EBITDA Margin was 172.21% for Q4 2021 at HUTCHMED (China), down from 339.61% in the prior quarter.
• Over five years, EBITDA Margin peaked at 339.61% in Q3 2021 and troughed at 303.37% in Q4 2018.
• A 4-year average of 18.22% and a median of 11.33% in 2018 frame the typical range for EBITDA Margin.
• Across the five-year window, EBITDA Margin plunged 37387 bps in 2019 and soared 31422 bps in 2020, its largest moves.
• Over 4 years, EBITDA Margin stood at 303.37% in 2018, then soared by 76 bps to 72.05% in 2019, then surged by 236 bps to 98.23% in 2020, then plunged by 275 bps to 172.21% in 2021.
• The last three EBITDA Margin figures came in at 172.21% (Q4 2021), 339.61% (Q3 2021), and 103.69% (Q2 2021), per Business Quant data.